Variant report
Variant | nsv979171 |
---|---|
Chromosome Location | chr2:213391107-213391783 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6435708 | chr2:213391114-213391115 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs564765312 | chr2:213391117-213391118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187900615 | chr2:213391136-213391137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6435709 | chr2:213391220-213391221 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs559389245 | chr2:213391223-213391224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146800528 | chr2:213391264-213391265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191308108 | chr2:213391312-213391313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573433933 | chr2:213391315-213391316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569654946 | chr2:213391416-213391417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530703689 | chr2:213391418-213391419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139500067 | chr2:213391471-213391472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570349058 | chr2:213391501-213391502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183849667 | chr2:213391504-213391505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7556832 | chr2:213391506-213391507 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs568071696 | chr2:213391545-213391546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535483702 | chr2:213391555-213391556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186920317 | chr2:213391560-213391561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575661993 | chr2:213391612-213391613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7573568 | chr2:213391696-213391697 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs573778637 | chr2:213391707-213391708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs16848762 | chr2:213391735-213391736 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs2178576 | chr2:213391750-213391751 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs562380101 | chr2:213391753-213391754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574438741 | chr2:213391759-213391760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2178575 | chr2:213391766-213391767 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs563363466 | chr2:213391771-213391772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Schizophrenia | 18990708 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:213382600-213391800 | Weak transcription | Brain Substantia Nigra | brain |
2 | chr2:213383600-213392200 | Weak transcription | Aorta | Aorta |
3 | chr2:213384400-213395400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:213388800-213392800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr2:213390600-213391600 | Weak transcription | Fetal Heart | heart |
6 | chr2:213391600-213399200 | Enhancers | Fetal Heart | heart |